AQR Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.49M | Buy |
154,298
+17,065
| +12% | +$379K | ﹤0.01% | 1984 |
|
|
2025
Q4 | $3.55M | Sell |
137,233
-3,168
| -2% | -$75.3K | ﹤0.01% | 1779 |
|
|
2025
Q3 | $3.62M | Sell |
140,401
-1,762
| -1% | -$43.3K | ﹤0.01% | 1641 |
|
|
2025
Q2 | $3.4M | Sell |
142,163
-34,620
| -20% | -$873K | ﹤0.01% | 1482 |
|
|
2025
Q1 | $4.39M | Sell |
176,783
-111,716
| -39% | -$2.67M | ﹤0.01% | 1188 |
|
|
2024
Q4 | $5.44M | Sell |
288,499
-257,709
| -47% | -$4.52M | 0.01% | 1063 |
|
|
2024
Q3 | $8.22M | Buy |
546,208
+478,595
| +708% | +$8.18M | 0.01% | 864 |
|
|
2024
Q2 | $1.93M | Buy |
67,613
+5,918
| +10% | +$168K | ﹤0.01% | 1460 |
|
|
2024
Q1 | $1.8M | Sell |
61,695
-81,079
| -57% | -$2.49M | ﹤0.01% | 1462 |
|
|
2023
Q4 | $4.82M | Buy |
142,774
+33,953
| +31% | +$993K | 0.01% | 966 |
|
|
2023
Q3 | $3.34M | Buy |
108,821
+68,061
| +167% | +$2.45M | 0.01% | 1094 |
|
|
2023
Q2 | $1.63M | Buy |
40,760
+11,696
| +40% | +$484K | ﹤0.01% | 1346 |
|
|
2023
Q1 | $1.19M | Buy |
+29,064
| New | +$1.16M | ﹤0.01% | 1481 |
|
|
2021
Q2 | – | Sell |
-7,867
| Closed | -$551K | – | 2278 |
|
|
2021
Q1 | $551K | Sell |
7,867
-7,877
| -50% | -$563K | ﹤0.01% | 1795 |
|
|
2020
Q4 | $942K | Sell |
15,744
-2,975
| -16% | -$174K | ﹤0.01% | 1536 |
|
|
2020
Q3 | $1.13M | Sell |
18,719
-31,197
| -62% | -$1.81M | ﹤0.01% | 1362 |
|
|
2020
Q2 | $2.62M | Sell |
49,916
-3,295
| -6% | -$138K | ﹤0.01% | 1041 |
|
|
2020
Q1 | $1.78M | Buy |
53,211
+23,685
| +80% | +$984K | ﹤0.01% | 1116 |
|
|
2019
Q4 | $1.34M | Sell |
29,526
-91,263
| -76% | -$3.88M | ﹤0.01% | 1421 |
|
|
2019
Q3 | $4.6M | Sell |
120,789
-16,652
| -12% | -$665K | 0.01% | 995 |
|
|
2019
Q2 | $5.98M | Sell |
137,441
-13,771
| -9% | -$585K | 0.01% | 922 |
|
|
2019
Q1 | $5.75M | Buy |
151,212
+73,862
| +95% | +$2.88M | 0.01% | 945 |
|
|
2018
Q4 | $3.33M | Buy |
77,350
+72,259
| +1,419% | +$3.37M | ﹤0.01% | 1073 |
|
|
2018
Q3 | $250K | Sell |
5,091
-20,143
| -80% | -$871K | ﹤0.01% | 2152 |
|
|
2018
Q2 | $809K | Sell |
25,234
-64,594
| -72% | -$2.23M | ﹤0.01% | 1803 |
|
|
2018
Q1 | $2.8M | Buy |
+89,828
| New | +$3.2M | ﹤0.01% | 1216 |
|
|
2015
Q3 | – | Sell |
-10,703
| Closed | -$757K | – | 2243 |
|
|
2015
Q2 | $757K | Sell |
10,703
-818
| -7% | -$64.4K | ﹤0.01% | 1632 |
|
|
2015
Q1 | $1.02M | Sell |
11,521
-5,886
| -34% | -$597K | ﹤0.01% | 1407 |
|
|
2014
Q4 | $1.54M | Sell |
17,407
-41,994
| -71% | -$3.97M | ﹤0.01% | 1421 |
|
|
2014
Q3 | $5.76M | Buy |
59,401
+44,900
| +310% | +$4.37M | 0.02% | 770 |
|
|
2014
Q2 | $1.33M | Sell |
14,501
-2,400
| -14% | -$183K | ﹤0.01% | 1499 |
|
|
2014
Q1 | $1.18M | Sell |
16,901
-18,900
| -53% | -$1.29M | ﹤0.01% | 1615 |
|
|
2013
Q4 | $2.06M | Sell |
35,801
-2,506
| -7% | -$132K | 0.01% | 1344 |
|
|
2013
Q3 | $1.84M | Sell |
38,307
-3,708
| -9% | -$135K | 0.01% | 1336 |
|
|
2013
Q2 | $1.22M | Buy |
+42,015
| New | +$1.22M | ﹤0.01% | 1473 |
|
Other funds holding PCRX
DPCM
VPM
VCM
